# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037666
Filing Date
2022-11-14
Accepted
2022-11-14 17:03:31
Documents
95
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | txmd-10q_20220930.htm iXBRL | 10-Q | 2503327
2 | EX-10.1 | txmd-ex101_163.htm | EX-10.1 | 88896
3 | EX-10.2 | txmd-ex102_164.htm | EX-10.2 | 85198
4 | EX-10.3 | txmd-ex103_165.htm | EX-10.3 | 102561
5 | EX-10.4 | txmd-ex104_162.htm | EX-10.4 | 74255
6 | EX-31.1 | txmd-ex311_9.htm | EX-31.1 | 18321
7 | EX-31.2 | txmd-ex312_48.htm | EX-31.2 | 18323
8 | EX-31.3 | txmd-ex313_8.htm | EX-31.3 | 18629
9 | EX-32.1 | txmd-ex321_7.htm | EX-32.1 | 8126
10 | EX-32.2 | txmd-ex322_49.htm | EX-32.2 | 8129
11 | EX-32.3 | txmd-ex323_6.htm | EX-32.3 | 8352
12 | GRAPHIC | gkoneh2dslj1000001.jpg | GRAPHIC | 4411
| Complete submission text file | 0001564590-22-037666.txt |  | 11110656

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL TAXONOMY EXTENSION SCHEMA | txmd-20220930.xsd | EX-101.SCH | 78243
14 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | txmd-20220930_cal.xml | EX-101.CAL | 60213
15 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | txmd-20220930_def.xml | EX-101.DEF | 262636
16 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | txmd-20220930_lab.xml | EX-101.LAB | 483885
17 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | txmd-20220930_pre.xml | EX-101.PRE | 439116
89 | EXTRACTED XBRL INSTANCE DOCUMENT | txmd-10q_20220930_htm.xml | XML | 2297700

Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 221387304
SIC: 2834 Pharmaceutical Preparations